A new framework from the US Food and Drug Administration includes plans to harmonize guidelines between departments to encourage the use of digital health technologies (DHT) in drug development.
Under the framework, the agency will host workshops with key stakeholders and develop internal processes for DHT evaluation and drug development. The document will also be used to promote learning...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?